BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246 AND Prognosis
4 results:

  • 1. Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials.
    González-Gil C; Morgades M; Lopes T; Fuster-Tormo F; García-Chica J; Zhao R; Montesinos P; Torrent A; Diaz-Beya M; Coll R; Hermosín L; Mercadal S; González-Campos J; Zamora L; Artola T; Vall-Llovera F; Tormo M; Gil-Cortés C; Barba P; Novo A; Ribera J; Bernal T; De Ugarriza PL; Queipo MP; Martínez-Sánchez P; Giménez A; González-Martínez T; Cladera A; Cervera J; Fernández-Martín R; Ardaiz MÁ; Vidal MJ; Baena Á; López-Bigas N; Bigas A; Maciejewski J; Orfao A; Ribera JM; Genescà E
    Haematologica; 2023 Apr; 108(4):969-980. PubMed ID: 36325893
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Methylation of DNA Repair Genes as a Prognostic Biomarker in AML of a TCGA-LAML Cohort.
    Park S; So MK; Huh J
    Clin Lab; 2022 Jul; 68(7):. PubMed ID: 35975527
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome.
    Ripperger T; Schlegelberger B
    Eur J Med Genet; 2016 Mar; 59(3):133-42. PubMed ID: 26743104
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and leukemia Group B Protocol 89803.
    Bertagnolli MM; Niedzwiecki D; Compton CC; Hahn HP; Hall M; Damas B; Jewell SD; Mayer RJ; Goldberg RM; Saltz LB; Warren RS; Redston M
    J Clin Oncol; 2009 Apr; 27(11):1814-21. PubMed ID: 19273709
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.